{"disease":{"id":"protein-losing-enteropathy-secondary-to-single-ventricle","name":"Protein-Losing Enteropathy Secondary to Single Ventricle","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:31:21.551Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":0,"pipeline_drug_count":1,"trial_count":0},"drugs":{"marketed":[],"pipeline":[{"drug_id":"odsh-at-0-125-mg-kg-h","indication_name":"Protein-Losing Enteropathy Secondary to Single Ventricle","indication_type":"pipeline","phase":"Phase 1","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ODSH at 0.125 mg/kg/h","company_name":"Jazz Pharmaceuticals","drug_phase":"discontinued","molecular_target":"Intestinal lymphatic proteins (albumin, immunoglobulins); mechanism targets protein loss pathway in enteropathy","drug_class":"Protein sequestrant; modified polysaccharide; orphan therapeutic","quality_score":null,"revenue":null,"mechanism":"ODSH is a modified chitosan polymer that binds intestinal lymphatic proteins to reduce protein loss in enteropathy."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}